CN102179011B - Infrared-ultraviolet composite therapeutic apparatus - Google Patents
Infrared-ultraviolet composite therapeutic apparatus Download PDFInfo
- Publication number
- CN102179011B CN102179011B CN 201110051842 CN201110051842A CN102179011B CN 102179011 B CN102179011 B CN 102179011B CN 201110051842 CN201110051842 CN 201110051842 CN 201110051842 A CN201110051842 A CN 201110051842A CN 102179011 B CN102179011 B CN 102179011B
- Authority
- CN
- China
- Prior art keywords
- ultraviolet
- infrared
- treatment
- infrared ray
- radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Radiation-Therapy Devices (AREA)
Abstract
The invention discloses an infrared-ultraviolet composite therapeutic apparatus, which is used for treating skin diseases through the combined action of infrared rays and ultraviolet rays. The infrared-ultraviolet composite therapeutic apparatus comprises an infrared and ultraviolet double light source, a lamp cover, a movable supporting rod, a power supply and a control platform, wherein the control platform comprises a double-switch control system, a temperature control system and a time control system. The infrared-ultraviolet composite therapeutic apparatus can irradiate the skin of each part of the human body and effectively treat various skin diseases, such as leucoderma and the like; and the infrared-ultraviolet composite therapeutic apparatus has the advantages of simpleness, safety and reliability in operation, obvious treatment effect, easiness in being accepted by patients, and the like.
Description
Technical field
The present invention relates to armarium, particularly a kind of with infrared ray and ultraviolet combined effect in the optical radiation therapeutic instrument of human body skin take the treatment vitiligo as main multiple dermatosis.
Background technology
The color of human skin main with epidermis in melanocyte (melanocytes, MC) synthesize melanocyte and melanocyte and be passed to that keratinocyte (keratinocytes, KC) is relevant on every side.Under the impact of solar radiation, Skin Cell can reduce/avoid by the adjustment and control system of self complexity the damage that solar radiation may cause cell, and wherein melanin granule is being played the part of the effect of similar superoxide dismutase.Melanin granule stops the damage of cell DNA, albumen and membrane lipid by absorbing, disperse products of oxidative stress, removing free radical, and then plays important skin defence and protective effect.Dermal exposure can cause skin tanning, photoaging and light canceration under daylight.It is main relevant with ultraviolet (ultraviolet, UV), especially ultraviolet B radiation (ultraviolet B, UVB) that research previously thinks that these change.But recently, increasing evidence shows that energy matter-Re main in the daylight (infrared ray) also has the effect of similar UV to Skin Cell, and same intermittent fever (infrared ray) also can increase Skin Cell to the toleration of UV.Although people have done a large amount of research in the UV radiation aspect the impact of MC physiology and pathologic function at present, but heat (infrared ray) is at the early-stage on the research of MC physiological function impact, and this is providing a wide space for us aspect thermotherapy treatment pigmented dermatosis.We know that skin is the important barrier that the protecting human body internal is not subjected to external environment damage (such as daylight, ray, mechanical stimulus etc.).Acute Sunlight exposure can cause light sunburn and light tanned; The daylight long-term irradiation can cause the photic damage of Skin Cell, produces photoaging and light canceration.Short-term or accept for a long time solar radiation no matter, the most obvious variation of skin is exactly that irradiated site forms erythema and pigmentation.Research finds that the melanin granule that melanocyte produces is the human body protective agent natural to daylight.Melanin granule passes through to absorb daylight, disperses products of oxidative stress, removes free radical, thereby stops the damage of sun-induced cell DNA, albumen and membrane lipid, and then plays important skin defense reaction.Pigmentation is exactly the result that skin directly is on the defensive to environmental stimuluses such as solar radiations.Daylight generally includes UV (290-400nm), visible light (400-760nm) and infrared ray (760nm-1mm) three parts.Research previously thinks that UV radiation especially UVB is the main matter that sun exposure causes all manifold effects of skin.In the past few years, the research of a large amount of daylight impression skin functions also mainly launches around UV.But recently, scholars recognize that gradually the infrared ray (mainly being the heat effect of its generation) that accounts for daylight gross energy 54.3% also has the effect of similar UV to skin, has positive protective effect with intermittent fever to the radiation-induced skin injury of UV.
People just find that some people that warm oneself by a fire for a long time or sit around by stove can get erythema ab igne a long time ago, and clinical manifestation is that the changes such as netted pigmentation, telangiectasis appear in the position that is exposed to heat.It is similar that these change the skin photoage that causes with UV.The same with UV, slow fever exposes and can cause directly that also epidermis thickens, pigment increases, corium elastic fibers tissue injury, even causes the Skin Cell canceration.Increasing research evidence shows that heat (infrared ray) exposes meeting coup injury cell and crganelle film, causes DNA damage, thereby directly causes skin melanism, aging and canceration, and can strengthen skin tanning, photoaging and the photic carcinous effect that UV causes.In addition, heat (infrared ray) also has increases Skin Cell to the effect of UV toleration.Research is found to immerse immediately after UVB shines skin in 40 ℃ of water and to be immersed in 30 ℃ of water its erythema than immediately and can shorten incubation period.But its erythemal effect of inducing can be than weakening in 30 ℃ of water; Menezes and Danno etc. confirm respectively that also infrared ray can obviously suppress the radiation-induced skin KC apoptosis of UVB and fibroblastic death.Boreham etc. find that heating bath has obviously increased toleration and the tanned reaction of skin to solar radiation in the psoriatic process of application heating bath (40 ℃ of water-baths, 2 times weekly, 8 all 1 courses for the treatment of) treatment.
The applicant also realizes in therapy of vitiligo for many years, and herbal fomentation (45 ℃, 30min, 1 times/day) can obviously improve leukodermic secondary color rate.The recent result of study of this seminar also tentative confirmation heat stress (〉=39 ℃, effect MC 60min) has direct melanotropin anabolic effect, has compared significant difference (P<0.05) with the blank group, and this acts on 42 ℃ and reaches maximum.Above-mentioned research all points out us heat may equally have important regulating action to the skin pigment system with UV, may have certain collaborative and protective effect between the two.Based on this, the applicant in 2008 national Dermatology Professional Committee's combination of Chinese and Western medicine pigment disease group " vitiligo practice guidelines " revision can proposition with thermotherapy as a kind of new therapy of vitiligo method, this proposal has obtained participant expert's consistent approval.So far, people have done a large amount of experimentatioies with regard to UV to the impact of MC physiological function, but the relation of heat and MC physiological function is known little about it.By literature search, we find only to have two pieces of relevant reports and result also to be not quite similar abroad, domesticly then still find no similar research.Nakazawa in 1998 etc. have at first compared people's epidermis MC to two kinds of main exogenous stimulation UVB and the cell effect of heat, found that: (42 ℃ of heat, 60min) and after UVB (20mJ/cm2) radiation treatment purification cultivates people's epidermis MC 3d, the MC dendron increases prolongation, cell space increases, the synthetic increase of cell tyrosinase activity and melanocyte, the rate of increase descend, but return to the Normal group level after 6 days; Heat and UVB have all promoted to have in KC-MC co-culture system and the organization engineering skin MC quantity of functional activity to increase.
We prove that by experiment the melanocyte of independent use infrared ray or ultraviolet radiation In vitro culture all can make the tyrosinase activity of cell and melanin content increase at present; after if two kinds of light sources of use in conjunction successively shine the melanocyte of In vitro culture; not only melanocytic tyrosinase activity and melanin content shine separately apparently higher than two kinds of light sources, and ultrared heat effect can also protect ultraviolet to melanocytic destruction effectively.
Although the vitiligo pathogenesis it be unclear that, but its main manifestations is skin pigment to be taken off to lose or go down and is the department of dermatologry common disease of feature, tissue pathology checking confirms that patients with vitiligo skin lesion basal layer melanocyte reduces or disappearance, this is the pathologic basis of vitiligo skin lesion formation just, so we alleviate exactly the melanocytic destruction in skin lesion district and strengthen the remaining melanocytic activity in skin lesion district the main principle when the treatment vitiligo, make its propagation, break up and move to the position of depigmentation, thereby reach the effect that makes the vitiligo secondary color.Although but the not clear several related causes approved by academia at present of the leukodermic real cause of disease have: autoimmune disorder, oxidative stress, theory of heredity etc., so we treat the mode that vitiligo generally all adopts Drug therapy, naturopathy and the therapeutic alliance of operative treatment several different methods.And the treatment vitiligo of using clinically now gets physical therapy apparatus and comprises the types such as narrow general ultraviolet B radiation (NB-UVB), 308nm excimer laser, long wave ultraviolet (UVA), mental retardation He-Ne Lasers, not yet sees infrared ray and infrared ray and the leukodermic equipment of ultraviolet co-therapy used.
NB-UVB can promote melanocyte proliferation by stimulating keratinocyte release basic fibroblast growth factor (bFGF) and endothelin-1 (ET-1), simultaneously it can also improve the activity of the MMP-2 (MMP-2) of melanocyte self and local focal adhesion kinase (FAK) and accelerate melanocytic migration, to reach the purpose that makes vitiligo skin lesion secondary color.In addition, NB-UVB can also make local skin T lymphocyte DNA form thymine dimer, the inducer T lymphocyte apoptosis, thus the immunne response that suppresses local skin also is one of leukodermic mechanism of action for the treatment of.The 308nm excimer laser is a kind of chlorination xenon (XeCl) excimer laser, and its wavelength is in the UVB scope.Research finds that the 308nm excimer laser can induce the T Lymphocyte Apoptosis of skin lesion local infiltration effectively, the effect of its inducer T lymphocyte apoptosis even be better than NB-UVB.UVA is the leukodermic physiotherapy for the treatment of of using clinically the earliest, it treats the machine-processed basic identical of leukodermic mechanism and other phototherapy, mainly be to reach a leukodermic purpose for the treatment of by the cellullar immunologic response of inhibition skin lesion part and for melanocyte provides a favourable propagation microenvironment, UVA has used a century nearly in treatment vitiligo field, its curative effect is to be worth sure, but its side effect is too much, so its position is substituted by NB-UVB and 308nm excimer laser gradually to a certain extent.Mental retardation helium neon laser vitiligo also is not widely used in clinical, finds with mental retardation He-Ne Lasers 3.0J/cm but there is the scholar to do in this respect some tentative researchs
2, 1~2 treatment 40 routine stable incidence segmental vitiligo weekly, after the mean treatment 17 times, skin lesion begins to occur secondary color, have 60% patient through secondary color area after the continuous treatment greater than 50%.In addition this scholar compared also that the blood flow at skin lesion positions before and after the treatment changes and the situation of replying of adrenoceptor after think that the mental retardation He-Ne Lasers may be to reach by repair function unusual sympathetic nerve to treat leukodermic purpose.
Although the curative effect of above therapeutic equipment still can, the side effect that its when treatment occurs still can not be despised, and sometimes patient's health is worked the mischief, and is unfavorable for the rehabilitation of patient disease.These therapeutic equipments of now clinical practice all are that maximization equipment operating power is large in addition, dosage control requires high, need the professional and technical personnel to operate, can not be used for family uses, the patient must regularly receive treatment to hospital, the very inconvenient patient compliance that causes is not high, thereby affects therapeutic effect.In addition, we also do not see and use separately clinically the leukodermic equipment of infrared therapy, so the present invention provides a kind of new treatment theory for leukodermic treatment especially not still to an improvement of present clinical other treatment instrument.
Summary of the invention
The object of the invention is to remedy the deficiency of single ultraviolet aspect the treatment vitiligo, the synergism of using infrared ray (mainly being heat effect) and ultraviolet promotion melanocyte activity improves the secondary color effect of the skin lesion treatment of patients with vitiligo, utilize simultaneously thermal effect should be able to obviously reduce ultraviolet to melanocytic destruction, thereby reduce the side effect of existing equipment treatment, this equipment is configured to a kind of medical-type and portable domestic type therapeutic instrument in addition, make things convenient for patient's use, thereby improved the compliance of patient treatment.
The objective of the invention is to be achieved through the following technical solutions:
This therapeutic instrument comprises infrared ray, the two light sources of ultraviolet, lampshade, mobilizable support bar and control station.Two light sources are sent by two identical infrared ray and quartz burner respectively, movable support bar has two movable Metallic rod to consist of (like the support bar of desk lamp), control station is provided with each one of two light source switch, one of infrared temperature control handle, each one of infrared ray and ultraviolet irradiation time setting knob.
Wherein: the lampshade that luminous lamp tube is installed can be done 360 ° of rotations around the longitudinal axis of fluorescent tube, make things convenient for the not ipsilateral skin lesion of patient exposure health, lampshade also can be done 180 ° of rotations around the transverse axis of fluorescent tube simultaneously, the height that movable support bar can the up-down adjustment light source in addition, this design from three kinds of different dimensions adjusted light source positions can be satisfied the treatment needs to any position skin lesion.
Control system of the present invention adopts the mode of separating control, and namely the switch of infrared light supply and ultraviolet source separates, and the exposure time control system of infrared light supply and ultraviolet source is separated, and this separation control mode is conducive to two kinds of light sources and carries out sequential radiation treatment.The present invention adds and has used the infrared temperature control system in addition, thereby makes the ultrared thermal effect would not be too high and cause skin scald or cross low and do not reach therapeutic purposes.
Description of drawings
Fig. 1: the melanocyte of In vitro culture purification
Fig. 2: melanocytic Masson-Fontana dyeing is identified
Fig. 3: the heat stress of different temperatures is on the impact of normal person's melanocyte proliferation rate of In vitro culture
Fig. 4: the UVB irradiation of various dose is on the impact of normal person's melanocyte proliferation rate of In vitro culture
Fig. 5: different condition is on the impact of melanocyte tyrosinase activity and melanin content
Annotate: * has compared significant difference P<0.05 with normal control, UVB and heat treatment group UVB or heat treatment group tyrosinase activity; # has compared significant difference P<0.05 with normal control, UVB and heat treatment group melanocyte amount.
Fig. 6: surface structure sketch map of the present invention.(numeral refers in the accompanying drawing: 1, infrared light supply switch; 2, ultraviolet source switch; 3, infrared temperature control knob; 4, infrared light exposure time setting device; 5, ultraviolet light irradiation time-setting mechanism; 6, lampshade; 7, infrared light supply fluorescent tube; 8, ultraviolet source fluorescent tube; 9, control station; 10, mobilizable support bar; 11, power supply)
Fig. 7: principle schematic of the present invention
Fig. 8: the floor map of two light sources
Fig. 9: control station sketch map
The specific embodiment
The invention will be further described below in conjunction with accompanying drawing.
Once how we confirm by experiment that ultrared heat effect and ultraviolet are to melanocytic collaborative facilitation to paper.
1, the melanocytic cultivation of normal person and going down to posterity: normal person's foreskin pruned help pachydermia, after the Dispase enzymic digestion with 5g/L, separate corium and epidermis, epidermis is with the digestion of 2.5g/L tryptic digestive juice and make single cell suspension, put the melanocyte culture fluid and (contain 5% FBS, 100U/ml penicillin and 100ug/ml streptomycin, the CDMB153 culture medium of bFGF) in, at 37 ℃, 5%CO
2Cultivate in the incubator, behind cell confluent cultures bottle, go down to posterity and cultivate the melanocyte that obtains purification, as shown in Figure 1.
2, melanocytic Masson-Fontana dyeing is identified: with the 3rd generation cell suspending liquid concentration transfer to 5 * 10
3/ ml is inoculated in the culture dish that diameter is 35mm, and every ware inoculation 1ml dyes behind the 24h.The optical microphotograph Microscopic observation, the melanin granule in the cell cytosol is black, and nucleus takes on a red color, and confirms that the cell that we obtain is melanocyte.As shown in Figure 2.
3, mtt assay is measured the ultraviolet radiation of different temperatures and various dose to the impact of the melanocytic proliferation activity of normal person of In vitro culture: select the 3rd generation cell, with 6 * 10
4The density of/ml is inoculated in respectively in the culture dish of 13 35mm, every hole 1.5ml.Behind the cell inoculation 24h, wherein 1 group at 37 ℃ of normal cultivate (matched groups), and wherein 5 groups respectively at 39 ℃, 41 ℃, 42 ℃, 43 ℃, 45 ℃, intervene under 5 different temperatures, intervene 1h every day, intervene continuously 3d; Other 7 groups respectively at 20mJ/cm
2, 30mJ/cm
2, 40mJ/cm
2, 50mJ/cm
2, 70mJ/cm
2, 90mJ/cm
2, 120mJ/cm
2Intervene under 7 different irradiation doses, intervene continuously 3 days all intervention group after last is intervened 20h, add the MTT solution of 5g/L in each culture dish, hatch 4h for 37 ℃.Discard liquid adding dimethyl sulfoxide (DMSO) in the culture plate, every ware 2.25ml, vibration 15min, under the 492nm wavelength, detect optical density value and calculate the rate of increase: cell proliferation rate (%)=(experimental group mean light absorbency-blank mean light absorbency)/(matched group mean light absorbency-blank mean light absorbency) * 100%, select suitable intervention condition as the condition of next step experiment, shown in accompanying drawing 3,4.
4, tyrosinase activity and melanin content are measured: will cultivate the 4th generation cell to transfer to concentration be 2 * 105/ml, be inoculated in respectively in 4 100mm culture dishs with every ware 4mL, behind the 24h respectively to adopting 37 ℃, 5%CO
2Normally hatch 42 ℃, 5%CO
2Condition lower every day of 1h intervenes 3d, 40mJ/cm continuously
2UVB every day 1 continuous intervention 3d and 42 ℃ of every days, 5%CO
2Horse back 40mJ/cm after intervention is finished under the condition
2UVB intervenes continuously and intervened 3 days, all groups are after last is intervened 24h, measure respectively activity and the melanin content of cell tryrosinase with reference to the method for Maeda and Virador etc., select 492nm wavelength place colorimetric, with the blank well zeroing, survey each hole absorbance and calculate the cell tyrosinase activity and the melanin content rate of increase.
Cell tyrosinase activity rate of increase=[(experimental group mean light absorbency-blank mean light absorbency) ÷ (matched group mean light absorbency-blank mean light absorbency)-1] * 100%.
Melanocyte synthesizes rate of increase=[(cell number of experimental group absorbance ÷ test group) ÷ (cell number of matched group absorbance ÷ matched group)-1] * 100%, obtains different interventions to the impact of melanocyte activity.As shown in Figure 5.
Secondly, detailed structure of the present invention and the workflow introduced
Shown in accompanying drawing 6,8,9, the present invention includes infrared ray, the two light sources of ultraviolet, movable support bar 10 and control station 9.The light source luminescent pipe places in the lampshade 6, lampshade 6 is fixed on the movable support bar 10 by a head, power supply and control circuit are along support bar 10 travelings, the lower end of support bar 10 is fixed on the control station 9, is respectively equipped with infrared light supply switch 1, ultraviolet source switch 2, infrared temperature control knob 3, infrared light exposure time setting device 4, ultraviolet source exposure time setting device 5 on the control station 9.Described infrared temperature control knob is controlled the temperature of infrared light supply by regulating and control voltage, described time-setting mechanism possesses the timer of control irradiation dose.
Workflow of the present invention: 1. light source position is regulated at the patient position for the treatment of as required; 2. open the infrared control switch, regulate time and the temperature that needs treatment according to dosage subordinate list (not providing); 3. the skin lesion that waits equipment work after 5 minutes needs to be carried out radiation treatment places the position of dosage subordinate list regulation, at first skin lesion is carried out infrared therapy; 4. infrared therapy is turned off the infrared light supply switch after finishing, and opens the ultraviolet source switch, regulates the used time of ultraviolet irradiation by dosage subordinate list (not providing) equally, carries out the ultraviolet light treatment; 5. treatment is turned off power supply after finishing, and whole treatment flow process finishes.
Because the sequential therapy of irradiation under ultraviolet ray behind the first Infrared irradiation has been adopted in this invention, not only can effectively improve the colour of skin effect of white macula skin lesion, and reduced the phototoxic action of ultraviolet light to Skin Cell, reduced the side effect of phototherapy, this also is that the present invention is than the advantage place of other similar therapeutic equipments of having used clinically at present.
Claims (5)
1. the leukodermic therapeutic instrument for the treatment of is characterized in that, this therapeutic instrument is comprised of infrared ray and the two light sources of ultraviolet B radiation, lampshade, mobilizable support bar and control station; The two light sources of described infrared ray and ultraviolet B radiation place described lampshade jointly, and described lampshade is fixed on described mobilizable support bar, and described support bar is fixed on the described control station; Described control station comprises biswitch control system, infrared temperature control system and time control system; The described infrared ray light source of being connected with ultraviolet B radiation connects with the gauge tap of being connected respectively, and biswitch is controlled respectively the luminous of two light sources; Described time controlled system is used for setting described infrared ray and ultraviolet B radiation exposure time.
2. the leukodermic therapeutic instrument for the treatment of according to claim 1 is characterized in that, the two light sources of described infrared ray and ultraviolet B radiation are luminous tube, place described lampshade, and lampshade is fixed on the described support bar by the device of an activity.
3. the leukodermic therapeutic instrument for the treatment of according to claim 1 is characterized in that, described mobilizable support bar can be done the activity that upper and lower makes progress, and can arrive the effect that can play fixing two light sources behind the assigned address at described pair of light source.
4. the leukodermic therapeutic instrument for the treatment of according to claim 1 is characterized in that, described infrared temperature control system is to control the temperature of infrared light supply by regulation and control voltage.
5. leukodermic therapeutic instrument according to claim 1 is characterized in that, described time controlled system possesses the timer of control irradiation dose.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110051842 CN102179011B (en) | 2011-03-04 | 2011-03-04 | Infrared-ultraviolet composite therapeutic apparatus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110051842 CN102179011B (en) | 2011-03-04 | 2011-03-04 | Infrared-ultraviolet composite therapeutic apparatus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102179011A CN102179011A (en) | 2011-09-14 |
CN102179011B true CN102179011B (en) | 2013-03-13 |
Family
ID=44565413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110051842 Active CN102179011B (en) | 2011-03-04 | 2011-03-04 | Infrared-ultraviolet composite therapeutic apparatus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102179011B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2492883C1 (en) * | 2011-12-29 | 2013-09-20 | Николай Николаевич Новиков | Ultraviolet and infrared phototherapeutic apparatus |
CN104383644A (en) * | 2014-12-18 | 2015-03-04 | 邱有英 | Desk-lamp-type infrared physiotherapeutic instrument |
CN105276518B (en) * | 2015-10-27 | 2018-04-17 | 刘红 | A kind of health-nutrition LED light source device |
CN115227711A (en) * | 2016-12-29 | 2022-10-25 | 上海交通大学 | Drug delivery method for increasing bioactivity of small interfering RNA sequence in skin by using infrared light |
CN106821981A (en) * | 2016-12-29 | 2017-06-13 | 上海交通大学 | A kind of infrared light increases activity RNA(RNAa)Sequence enters skin and produces the medication of bioactivity |
WO2018121674A1 (en) * | 2016-12-29 | 2018-07-05 | 上海交通大学 | Administration method using infrared light to enhance biological activity of rna sequence in skin |
CN109966650A (en) * | 2017-12-28 | 2019-07-05 | 广东百视特照明电器有限公司 | A kind of Led treating herpes instrument and treatment method |
US11474038B2 (en) * | 2018-02-05 | 2022-10-18 | Shiseido Company, Ltd. | Method for evaluating protective effect against external damage to skin |
CN115091668A (en) * | 2022-05-27 | 2022-09-23 | 国营芜湖机械厂 | Dual light source photo-thermal curing method suitable for emergency repair of outfield complex structure |
CN116617586B (en) * | 2023-05-25 | 2024-01-23 | 北京工业大学 | Light control system for ultraviolet crosslinking auxiliary infrared light irradiation, application and method |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1859947A (en) * | 2003-09-30 | 2006-11-08 | 库雷莱特有限公司 | Phototherapeutic treatment of skin conditions |
CN2875490Y (en) * | 2005-01-19 | 2007-03-07 | 苏柏衡 | Radiation therapeutical apparatus |
WO2008110963A1 (en) * | 2007-03-09 | 2008-09-18 | Philips Intellectual Property & Standards Gmbh | Phototherapy apparatus for treatment of skin disorders |
CN201337766Y (en) * | 2008-12-31 | 2009-11-04 | 张洪冰 | Photodynamic energy therapeutic instrument for leucoderma |
CN101721773A (en) * | 2008-10-29 | 2010-06-09 | 北京市赛思创科技发展有限责任公司 | Equipment for treating vitligo by utilizing turnable lattice dual wavelength laser |
WO2011001344A2 (en) * | 2009-06-30 | 2011-01-06 | Koninklijke Philips Electronics N.V. | Light treatment system |
-
2011
- 2011-03-04 CN CN 201110051842 patent/CN102179011B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1859947A (en) * | 2003-09-30 | 2006-11-08 | 库雷莱特有限公司 | Phototherapeutic treatment of skin conditions |
CN2875490Y (en) * | 2005-01-19 | 2007-03-07 | 苏柏衡 | Radiation therapeutical apparatus |
WO2008110963A1 (en) * | 2007-03-09 | 2008-09-18 | Philips Intellectual Property & Standards Gmbh | Phototherapy apparatus for treatment of skin disorders |
CN101721773A (en) * | 2008-10-29 | 2010-06-09 | 北京市赛思创科技发展有限责任公司 | Equipment for treating vitligo by utilizing turnable lattice dual wavelength laser |
CN201337766Y (en) * | 2008-12-31 | 2009-11-04 | 张洪冰 | Photodynamic energy therapeutic instrument for leucoderma |
WO2011001344A2 (en) * | 2009-06-30 | 2011-01-06 | Koninklijke Philips Electronics N.V. | Light treatment system |
Also Published As
Publication number | Publication date |
---|---|
CN102179011A (en) | 2011-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102179011B (en) | Infrared-ultraviolet composite therapeutic apparatus | |
Caldieraro et al. | Transcranial and systemic photobiomodulation for major depressive disorder: A systematic review of efficacy, tolerability and biological mechanisms | |
Hamblin | Mechanisms and applications of the anti-inflammatory effects of photobiomodulation | |
Lin et al. | Evaluation of the effect of laser acupuncture and cupping with ryodoraku and visual analog scale on low back pain | |
Wurtman | The effects of light on the human body | |
Sowa et al. | Optical radiation in modern medicine | |
Lin et al. | Clinical effects of laser acupuncture plus Chinese cupping on the pain and plasma cortisol levels in patients with chronic nonspecific lower back pain: a randomized controlled trial | |
Azeemi et al. | The mechanistic basis of chromotherapy: Current knowledge and future perspectives | |
Chen et al. | Irradiance plays a significant role in photobiomodulation of B16F10 melanoma cells by increasing reactive oxygen species and inhibiting mitochondrial function | |
US20180193664A1 (en) | Trans-Orbital Infrared Light Therapy | |
CN110141750A (en) | A kind of multipurpose wide spectrum therapeutic equipment | |
Cho et al. | Neurite growth of trigeminal ganglion neurons in vitro with near-infrared light irradiation | |
CN105662905A (en) | Application of dihydromyricetin in preparation of skin-care products or drugs for preventing and treating optical skin injuries | |
Zhu et al. | Comparison of NB‐UVB combination therapy regimens for vitiligo: A systematic review and network meta‐analysis | |
Yao et al. | Transcranial near-infrared laser therapy in improving cognitive recovery of function following traumatic brain injury | |
Xu et al. | Recent advances in low-level laser therapy on depression | |
KR20080094642A (en) | Chair type light therapeutic device on meridian | |
Holick et al. | Biologic Effects of Light: Proceedings of the Symposium, Atlanta, Georgia, USA, October 13–15, 1991 | |
SK5457Y1 (en) | Nasal applicator for intranasal laser irradiation of blood | |
KR101025473B1 (en) | Light Therapeutic Device on Meridian | |
Holick et al. | Biologic effects of light | |
Lim | The Potential of intranasal light therapy for brain stimulation | |
CN105561478A (en) | Application of far infrared water body thermotherapy | |
CN102283770A (en) | Fumigation-washing sit bathing device | |
Harris | Studies on the biological action of light |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |